XZ739 in combination with S63845 has synergistic antitumor effects in CRPC cell lines. A to I, CellTiter-Glo viability data from 2D cultures of LNCaP95, VCaP-CR, and 22Rv1 cell lines. Cell viability data for the dual treatment (A–C) were generated by CellTiter-Glo. Dose–response matrices (D–F) and Bliss synergy plots (G–I) were created using the SynergyFinder+ R package. J to M, 3D spheroid model and cell viability of LNCaP95 (J and K) and 22Rv1 cells (L and M). Data are presented as mean ± SD. **, P < 0.01; ****, P < 0.0001. All experiments were completed in triplicate. Spheroid images are representative of three replicates.
No takes yet. Share an insight, caveat, or question.
Brim et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: